ABSTRACT

This handbook provides an in-depth review of information across the developmental spectrum of gene and cell therapy products. From introductory information to state-of-the-art technologies and concepts, the book provides insights into upstream processes such as vector design and construction, purification, formulation and fill/finish, as well as delivery options. Planning steps for compliance with current good manufacturing practice (cGMP) to readiness for chemistry, manufacturing and controls (CMC) are also discussed. This book wraps up with examples of successes and pitfalls addressed by experts who have navigated the multiple challenges that are part of any innovative endeavor.

Features

  • Provides the most up-to-date information on the development of gene therapy, from the technology involved to gene correction and genome editing
  • Discusses siRNA, mRNA, and plasmid manufacturing
  • Describes the importance of supplier-sponsor synergies on the path to commercialization
  • Written for a diverse audience with a large number of individuals in the core technologies and supportive practices

It is intended as a one-stop resource for the availability of state-of-the-art information related to cell and gene therapy products for researchers, scientists, management and other academic and research institutions.

chapter 1|12 pages

History of Gene Therapy Products

chapter 2|14 pages

Gene Editing in Humans

How Bioethics Discussions Can Guide Responsible Research and Product Development

chapter 4|14 pages

Gene Therapy Products

Basics and Manufacturing Considerations

chapter 5|15 pages

Cell Therapy Products

Basics and Manufacturing Considerations

chapter 13d1|12 pages

Regulatory Landscape in Singapore

chapter 13d2|14 pages

Regulatory Landscape in Malaysia

chapter 13e|16 pages

Regulatory Landscape in China

chapter 13f|10 pages

Regulatory Landscape in Japan

chapter 13g|15 pages

Regulatory Landscape in India